When a fringe lunatic is put in charge of the nation’s health, terrible outcomes will most certainly become part of life as we will come to know it in the ...

Biotechnology company United Therapeutics (NASDAQ:UTHR) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 19.7% year on year to $735.9 million. Its GAAP profit of $6.19 per ...

Piotr Swat / SOPA Images / LightRocket via Getty Images Summit Therapeutics shares dropped 14% Monday as it reported a fourth-quarter adjusted loss nearly double that of the previous year.

Viking Therapeutics (NASDAQ:VKTX) quickly soared 12% amid some renewed takeover speculation for the obesity drug maker. There's some renewed speculation Viking (NASDAQ:VKTX) may be a takeover ...

Prelude Therapeutics Reports Full Year 2024 Financial Results and Provides Program Outlook for 2025 Prelude Therapeutics, Incorporated - (GLOBE NEWSWIRE) Mar 10, 2025 ...

In a report released today, Sarah Schram from William Blair maintained a Buy rating on Ovid Therapeutics (OVID – Research Report). The company’s shares closed yesterday at $0.49. Effectively ...

E @7 E96 9@FD6 5:5 :?92=6 D@>6 D>@6?E @? D:E6] w@H6G6C[ D96 H2D E26C86?4J C@@> :? 2 A6CD@?2= G69:4=6]k^Am kAm{66 D2:5 E96 7:G6 A6@A=6 2?5 D6G6C2= A6ED E92E =:G6 2E E96 9@>6 H6C6 ?@E 23=6 E@ DE2J E96C6 ...

A digital therapeutics start-up which uses augmented reality (AR) glasses to aid people suffering from disorders including Parkinson's disease and multiple sclerosis will this week announce a £ ...

A rumor regarding Viking Therapeutics (VKTX) was highlighted in an alert sent to subscribers of Ben Harrington’s takeover-focused Betaville blog, contacts tell The Fly. Published first on TheFly ...